Advertisement · 728 × 90
#
Hashtag
#ACTRIMS
Advertisement · 728 × 90
Post image

If you enjoyed #ACTRIMSForum 2026 over the weekend, why not review our resources on multiple sclerosis (MS) to catch up with the guideline updates and latest news you need to know #MedSky #ACTRIMS #MS #MultipleSclerosis #MedEd

ow.ly/Fb7650YbGNV

2 1 0 0
Post image Post image Post image Post image

🎤 We are offically on the ground at #ACTRIMSForum

Stay tunes for real-time insights, expert perspectives, and key takeaways from the MS community—straight from the conference floor 👨‍⚕️

Follow all of NeurologyLive's social media platforms for updates❗
#ACTRIMS2026 #ACTRIMS #Neurology #MS

0 0 0 0
Post image

Stanford Neuroimmunology showed up and out at #ACTRIMS 2025. The future is looking bright 🧠😎

0 0 0 0
Preview
Welche MS-Subtypen gibt es? Die neuen molekularbiologischen Erkenntnisse kratzen an den althergebrachten Kategorien.

Man kann Multiple Sklerose als ein Krankheitsspektrum sehen, in dem die Erkrankten unterschiedliche Phasen durchlaufen. Vielleicht gibt es aber auch klar definierbare Subtypen mit unterschiedlichen Verläufen. Auf der #ACTRIMS-Tagung gab es dazu unterschiedliche Auffassungen. (Reg.) #medsky #ms

1 0 0 0
Post image

Neuroimmunology Fellow Dr. Jacob Loeffler presents a case series on CNS demyelination following TNFI exposure.
#ACTRIMS #ACRIMS2025

1 0 0 0
Post image

Dr. Dunn presented results at #ACTRIMS: CAR-T (CD-19) treatment in a patient with progressive MS was well tolerated with improvement in EDSS, MFIS, and eradication of CSF oligoclonal bands. #MultipleSclerosis #MSResearch #ACTRIMS2025

1 0 0 0
Preview
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies In patients with multiple sclerosis, lesions in white matter can disrupt brain connectivity, leading to cognitive and motor impairments. Join Dr. Amy Kuceyeski as she discusses the pathophysiology beh...

I presented our work on estimating network effects of brain lesions in multiple sclerosis today at #ACTRIMS - for more info, see my short interview! reachmd.com/programs/neu...

7 2 0 0
Post image

Interesting pathology talk by Kevin O'Connor at #ACTRIMS. strong laboratory evidence that MOG antibodies are indeed pathogenic in #MOGAD with compliment and NK cell mediated cell destruction. Implications for future clinical research.

1 0 0 0
Post image

I'm attending The 10th anniversary #ACTRIMS. I attended as a part of the resident summit in the 2nd year. Now as faculty, I'm supporting the Barrow neuroimmunology fellow Rachna Khanna who is presenting and learning here. Happy to now to be a part of training the future of MS specialists.

0 0 0 0
Post image

🧪The #ACTRIMS forum always has a session dedicated to ECRs to give them the opportunity to showcase their research and build their network. Here's our exciting #ACTRIMS2025 young investigator session on emerging concepts in MS, covering basic, translational and clinical science. See you there!

6 3 0 0
Post image

We're excited to be at #ACTRIMS next month in West Palm Beach🌴Let us know if you'll be there too!

#NMOSD #MOGAD #MS

0 0 0 0
3D animation still of a transparent head with fully visible brain, created by our award-winning in-house animation team; grey background. Text: "Meet Red Nucleus (logo) at the ACTRIMS Forum 2024" 
Hashtag #ACTRIMSForum

3D animation still of a transparent head with fully visible brain, created by our award-winning in-house animation team; grey background. Text: "Meet Red Nucleus (logo) at the ACTRIMS Forum 2024" Hashtag #ACTRIMSForum

Meet the Red Nucleus team at #ACTRIMSForum 2024! Learn how we're expanding what's possible in Learning & Development and Medical Communications.

Hope to see you there—or contact us at the link.
🔴🧠
#ACTRIMS #MultipleSclerosis #medcomms #LD
🔗 rednucleus.com/contact

2 0 1 0